"Virological characteristics of the SARS-CoV-2 JN.1 variant"
The Lancet Infectious Diseases Online 03 January 2024 doi:10.1016/S1473-3099(23)00813-7
Emergence of SARS-CoV-2 Variant JN.1 Raises Concerns with Increased Transmissibility and Immune Evasion
Description
Published Article
Yu Kaku1, Kaho Okumura1, Miguel Padilla-Blanco2, Yusuke Kosugi1, Keiya Uriu1, Alfredo A Hinay Jr1, Luo Chen1, Arnon Plianchaisuk1, Kouji Kobiyama3, Ken J Ishii3, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Jiri Zahradnik2, Jumpei Ito1, Kei Sato1
1 Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
2 First Medical Faculty at Biocev, Charles University, Prague, Czechia
3 Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
1 Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
2 First Medical Faculty at Biocev, Charles University, Prague, Czechia
3 Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
